Ready for your all-in-one single cell sequencing solution?


Tumor heterogeneity is a significant obstacle in the efficacy of cancer treatments, encompassing genomic diversity, transcriptomic variations, and disparities in the immune microenvironment. This complexity often impedes the success of therapeutic interventions.

Single cell sequencing technology allows to delineate various cell types and cell states, including tumor cells and tumor-related immune cells. This method is powerful for studying tumor heterogeneity and the characteristics of the immune microenvironment. It helps to understand disease mechanisms, discover the causes of drug resistance, and facilitates the development of novel treatments.

Entering a Rare Research Field?

Entering a Rare Research Field?

Are you planning a project with difficult tissue types? Being a pioneer is not easy, but we are here to help!